Table 1. Epidemiological studies describing incidence and serogroups of invasive meningococcal disease.
Paper | Study area | Study period | Study design | Participant population | Number of participants | Incidence | Dominant serogroups (increases) | |
Studies before serogrouping was introduced | ||||||||
Houston et al.22 | England | 1907–1940 | Epidemiological analysis | Cases | ||||
Arkwright21 | England, France | 1915 | Epidemiological analysis | Cases | Group B and P | |||
Pringle23 | England | 1915–1917 | Epidemiological analysis | Cases | ||||
Fairbrother20 | England | 1940–1947 | Epidemiological analysis | Cases | Group II | |||
Studies after serogrouping was introduced | ||||||||
Puricelli et al.47 | Brazil | 1971–2000 | Epidemiological analysis | Cases | 7893 | 6.4 | B | C |
de Cassia et al.48 | Brazil | 1987–2003 | Epidemiological analysis | Cases | 5512 | 7.9 | B | C |
Barroso et al.49 | Brazil | 1990–1996 | Epidemiological analysis | Cases | 2338 | – | B | C |
Baethgen et al.50 | Brazil | 1995–2003 | Epidemiological analysis | Cases | 2215 | 3.5–1.8 | B | C |
Cordeiro et al.51 | Brazil | 1996–2000 | Epidemiological analysis | Cases | 408 | 1.7 | B | C |
Iser et al.52 | Brazil | Jun–Sept 2008 | Case–control | Patients neighbouring households | 8 cases 32 controls | 12 | C | – |
Olivares et al.32 | France | 1987–1988 | Epidemiological analysis | Cases | 1132 | 0.7 | B | C |
Perrocheau et al.44 | France | 2003 | Epidemiological analysis | cases | 803 | 1.8 | B | C |
Grahlow et al.26 | Germany | 1971–1984 | Epidemiological analysis | Cases | 650 | – | B | C |
Tzanakaki et al.36 | Greece | 1989–1991 | Epidemiological analysis | Cases | 31 | – | B | C |
Kafetzis et al.41 | Greece | 1993–2004 | Epidemiological analysis | Cases | 1144 | – | B | C (A, W135) |
Tsolia et al.35 | Greece | 1999–2000 | Epidemiological analysis | Cases | 157 | 10.2 | B | C (A) |
Berild et al.28 | Norway | 1967–1979 | Epidemiological analysis | Cases | – | 24–43 | A, B | – |
Bovre et al.30 | Norway | 1975–1979 | Epidemiological analysis | Cases | 1574 | 7.8 | B | – |
Lystad et al.31 | Norway | 1975–1991 | Epidemiological analysis | Cases | – | 15–4.1 | B | C |
Iversen et al.29 | Norway | 1992–1995 | Epidemiological analysis | Cases | 586 | 3.4 | B | C |
Wylie et al.38 | England | 1982–1995 | Epidemiological analysis | Cases | 252 | 5.6 | ||
Stanton et al.27 | England | 1977–2007 | Epidemiological analysis | Cases | 1157 | – | B | C |
Gray et al.39 | England and Wales | 1993–2004 | Epidemiological analysis | Cases | 21 711 | 2.3–5.4 | B | C |
Shigematsu et al.40 | England, Wales, and Northern Ireland | 1999–2001 | Epidemiological analysis | Cases | 11 522 | 9.2–8.0 | B | C (W135) |
Demina et al.33 | USSR | 1980–1984 | Epidemiological analysis | Cases | 2653 | – | A | B |
Connolly et al.34 | Europe | 1993–1996 | Epidemiological analysis | Cases from 35 countries | 16 734 | 1.1 | B | C |
Trotter et al.72 | Europe | 1999–2004 | Epidemiological analysis | Cases from 27 countries | – | 0.2–5.4 | B | C |